Cargando…
Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
This article attempts to define terminology and to describe a process for writing adaptive, early phase study protocols which are transparent, self-intuitive and uniform. It provides a step by step guide, giving templates from projects which received regulatory authorisation and were successfully pe...
Autores principales: | Lorch, Ulrike, O’Kane, Martin, Taubel, Jorg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096541/ https://www.ncbi.nlm.nih.gov/pubmed/24980283 http://dx.doi.org/10.1186/1471-2288-14-84 |
Ejemplares similares
-
The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study
por: Ferber, Georg, et al.
Publicado: (2015) -
Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers
por: Lorch, Ulrike, et al.
Publicado: (2020) -
Blinding Is Seeing: A Single-Centre Study Into the Viability of Auto-Injectors for Blinded-Drug Administration in Randomised Controlled Trials
por: Aggarwal, Vishal, et al.
Publicado: (2023) -
Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
por: Coates, Simon, et al.
Publicado: (2020) -
The Reliability of Auto-Injectors in Clinical Use: A Systematic Review
por: Dostal, Petr, et al.
Publicado: (2023)